Exogems is a biotechnology company that produces therapeutic exosomes from adipose tissue.
Exogems has raised $590K in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Exogems is headquartered in Epalinges, Switzerland.
Exogems is a biotechnology company that produces therapeutic exosomes from adipose tissue.
Exogems is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Exogems — Funding & Investors." VCBacked, August 29, 2024, https://www.vcbacked.co/company/exogems. Accessed August 14, 2026.
VCBacked. (2024). Exogems — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/exogems
{{cite web |title=Exogems — Funding & Investors |url=https://www.vcbacked.co/company/exogems |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated